Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Sep 24:2021:9313201.
doi: 10.1155/2021/9313201. eCollection 2021.

Efficacy and Safety of Stem Cell Combination Therapy for Osteonecrosis of the Femoral Head: A Systematic Review and Meta-Analysis

Junqiao Li  1 , Peng Su  1 , Jian Li  1 , Gang Chen  1 , Yan Xiong  1
Affiliations
Meta-Analysis

Efficacy and Safety of Stem Cell Combination Therapy for Osteonecrosis of the Femoral Head: A Systematic Review and Meta-Analysis

Junqiao Li et al. J Healthc Eng. .

Abstract

Background: The treatment results of core decompression (CD) and biomechanical support are not always satisfactory in osteonecrosis of the femoral head (ONFH). Stem cell therapy has been incorporated into traditional treatment in order to promote bone regeneration. The efficacy and safety of stem cell therapy combined with CD or biomechanical support on advanced and long-term patients with ONFH were unknown. The aim of this study was to assess whether stem cell combination therapy is superior to single CD or porous tantalum rod implantation treatment in ONFH.

Methods: A systematic search of the literature was performed to evaluate all included randomized controlled trials (RCTs) on stem cell combination therapy for patients with ONFH in PubMed, Cochrane Library, Web of Science, and Embase sites. We assessed the quality and risk of bias for the included studies. And the outcomes of Harris hip score (HHS), visual analogue scale (VAS), and adverse events were statistically analyzed.

Results: We included 10 randomized controlled trials, containing a total of 498 patients with 719 hips. Stem cell therapy combined with CD versus CD alone for HHS of ONFH was different (MD = 8.87, 95% CI = [5.53, 12.22], P < 0.00001). The combination of stem cell therapy and CD can effectively improve HHS. Similarly, the VAS of the stem cell combination therapy group also differed compared with the control group (MD = -14.07, 95% CI = [-18.32, -9.82], P < 0.00001). The result showed that stem cell combination therapy can relieve the pain of patients with ONFH. There was no significant difference in adverse response outcome events between the combination therapy group and the control group (RR = 1.57, 95% CI = [0.62, 3.97], P = 0.34).

Conclusions: Stem cell therapy combined with core decompression is an effective and feasible method with few complications in the clinical treatment of early-stage ONFH. Even in the combination of porous tantalum rod implantation and peripheral blood stem cells, stem cell combination therapy is superior to single biomechanical support treatment. But high-quality, large-sample, multicenter, and long-term follow-up RCTs are still needed to corroborate the efficacy and safety of stem cell combination therapy in ONFH treatment.

PubMed Disclaimer

Conflict of interest statement

All authors declare no conflicts of interest with this work.

Figures

Figure 1
Figure 1
Flowchart of literature searching and screening process.
Figure 2
Figure 2
Bias graph risk.
Figure 3
Figure 3
Bias summary risk.
Figure 4
Figure 4
Forest plot of HHS.
Figure 5
Figure 5
Forest plot of VAS.
Figure 6
Figure 6
Forest plot of adverse events.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Larson E., Jones L. C., Goodman S. B., Koo K.-H., Cui Q. Early-stage osteonecrosis of the femoral head: where are we and where are we going in year 2018? International Orthopaedics . 2018;42(7):1723–1728. doi: 10.1007/s00264-018-3917-8. - DOI - PubMed
    1. Learmonth I., Maloon S., Dall G. Core decompression for early atraumatic osteonecrosis of the femoral head. Journal of Bone & Joint Surgery, British Volume . 1990;72-B(3):387–390. doi: 10.1302/0301-620x.72b3.2341433. - DOI - PubMed
    1. Koo K., Kim R., Ko G., Song H., Jeong S., Cho S. Preventing collapse in early osteonecrosis of the femoral head. a randomised clinical trial of core decompression. Journal of Bone & Joint Surgery, British Volume . 1995;77-B(6):870–874. doi: 10.1302/0301-620x.77b6.7593097. - DOI - PubMed
    1. Wang Z., Sun Q.-M., Zhang F.-Q., Zhang Q.-L., Wang L.-G., Wang W.-J. Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: a meta-analysis. International Journal of Surgery . 2019;69:23–31. doi: 10.1016/j.ijsu.2019.06.016. - DOI - PubMed
    1. Hauzeur J.-P., De Maertelaer V., Baudoux E., Malaise M., Beguin Y., Gangji V. Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. International Orthopaedics . 2018;42(7):1429–1435. doi: 10.1007/s00264-017-3650-8. - DOI - PubMed

LinkOut - more resources